Company logo

EVH - Evolent Health, Inc.

NYSE -> Healthcare -> Health Information Services
Arlington, United States
Type: Equity

EVH price evolution
EVH
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $192.82 $184.54 $142.53 $157.52
Short term investments $13.77 $23.21 $47.48 $21.93
Net receivables $446.75 $394.23 $345.28 $262.76
Inventory
Total current assets $683.67 $638.8 $576.7 $475.97
Long term investments $21.76 $21.62 $21.85 $16.63
Property, plant & equipment $90.18 $97.31 $111 $133.01
Goodwill & intangible assets $1868.55 $1895.21 $1919.48 $1943.8
Total noncurrent assets $1996.63 $2030.82 $2070.13 $2113.49
Total investments $35.53 $44.83 $69.32 $38.56
Total assets $2680.31 $2669.61 $2646.83 $2589.46
Current liabilities
Accounts payable $48.25 $51.78 $76.95 $51.01
Deferred revenue $5.98 $5.76 $6.95 $7.07
Short long term debt $9.74 $13.96 $6.22 $4.61
Total current liabilities $674.24 $615.29 $540.9 $457.65
Long term debt $635.06 $639.6 $689.59 $686.55
Total noncurrent liabilities $759.94 $782.62 $839.88 $839.44
Total debt $644.8 $653.55 $695.81 $691.16
Total liabilities $1434.18 $1397.92 $1380.78 $1297.09
Shareholders' equity
Retained earnings -$719.19 -$685.78 -$660.46 -$626.14
Other shareholder equity -$1.26 -$1.26 -$1.11 -$1.12
Total shareholder equity $1067.7 $1096.09 $1093.22 $1121.74
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $192.82 $188.2 $266.28 $340.49
Short term investments $13.77 $14.49 $75.69 $18.3
Net receivables $446.75 $254.68 $130.6 $125.99
Inventory
Total current assets $683.67 $478.05 $523.96 $546.13
Long term investments $21.76 $16.94 $18.43 $24.69
Property, plant & equipment $90.18 $136.9 $131.57 $144.04
Goodwill & intangible assets $1868.55 $1165.56 $706.08 $622.81
Total noncurrent assets $1996.63 $1339.24 $895.5 $824.05
Total investments $35.53 $31.43 $94.12 $42.98
Total assets $2680.31 $1817.29 $1419.46 $1370.18
Current liabilities
Accounts payable $48.25 $57.17 $96.08 $32.07
Deferred revenue $5.98 $5.76 $11.94 $14.33
Short long term debt $9.74 $7.12 $7.07 $33.91
Total current liabilities $674.24 $433.44 $445.49 $401.78
Long term debt $635.06 $412.99 $273.4 $325.87
Total noncurrent liabilities $759.94 $524.43 $280.33 $348.81
Total debt $644.8 $476.12 $280.47 $359.78
Total liabilities $1434.18 $957.88 $725.83 $750.59
Shareholders' equity
Retained earnings -$719.19 -$606.15 -$626.78 -$589.18
Other shareholder equity -$1.26 -$1.18 -$0.36 -$0.28
Total shareholder equity $1067.7 $859.42 $693.63 $619.6
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $556.05 $511.01 $469.14 $427.69
Cost of revenue $454.43 $386.58 $351.94 $310.48
Gross Profit $101.63 $124.43 $117.2 $117.22
Operating activities
Research & development
Selling, general & administrative $81.43 $96.57 $90.39 $89.73
Total operating expenses $117.04 $131.07 $146.59 $119
Operating income -$15.41 -$6.64 -$29.39 -$1.79
Income from continuing operations
EBIT -$14.59 -$24.13 -$20.84 -$75.28
Income tax expense -$14.66 -$5.55 -$0.97 -$68.19
Interest expense $12.24 $14.61 $14.46 $12.89
Net income
Net income -$12.18 -$33.2 -$34.32 -$19.98
Income (for common shares) -$41.4 -$33.2 -$41.41 -$26.26
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $1963.9 $1352.01 $907.96 $1022.43
Cost of revenue $1503.43 $1035.43 $657.55 $789.32
Gross Profit $460.47 $316.58 $250.41 $233.11
Operating activities
Research & development
Selling, general & administrative $358.11 $269.27 $219.5 $222.6
Total operating expenses $513.7 $336.46 $292.82 $503.73
Operating income -$53.23 -$19.88 -$42.41 -$270.62
Income from continuing operations
EBIT -$148.2 -$46.97 -$11.69 -$309.46
Income tax expense -$89.36 -$43.38 $0.48 -$3.55
Interest expense $54.2 $15.57 $25.43 $28.34
Net income
Net income -$113.04 -$19.16 -$37.6 -$334.25
Income (for common shares) -$142.26 -$19.16 -$37.6 -$334.25
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$12.18 -$33.2 -$34.32 -$19.98
Operating activities
Depreciation $29.6 $32.4 $32.13 $29.27
Business acquisitions & disposals $0.58 -$1.52 -$386.72
Stock-based compensation $10.6 $10.22 $8.97 $10.71
Total cash flows from operations $89.38 $60.52 $0.65 -$7.97
Investing activities
Capital expenditures -$6.05 -$6.79 -$6.84 -$9.05
Investments $0.07 $0.01 $0.79
Total cash flows from investing -$6.05 -$6.14 -$8.35 -$394.99
Financing activities
Dividends paid
Sale and purchase of stock $3.34 $4.53 $3.07 $1.58
Net borrowings -$34.71 -$35.2 $25.28 $226.41
Total cash flows from financing -$84.35 -$37.37 $23.33 $379.73
Effect of exchange rate -$0.02 -$0.11 -$0 $0.05
Change in cash and equivalents -$1.04 -$23.19
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$113.04 -$19.16 -$37.6 -$334.25
Operating activities
Depreciation $123.42 $67.19 $60.04 $61.48
Business acquisitions & disposals -$387.67 -$226.31 -$2.53 $159.46
Stock-based compensation $40.5 $33.98 $16.71 $14.61
Total cash flows from operations $142.58 -$11.55 $38.75 -$16.23
Investing activities
Capital expenditures -$28.75 -$38.36 -$24.98 -$29.47
Investments $0.87 $5.55 $11.72 $133.38
Total cash flows from investing -$415.54 -$259.12 -$15.79 $261.07
Financing activities
Dividends paid
Sale and purchase of stock $12.52 $4.45 $13.29 $2.58
Net borrowings $181.78 $160.29 -$37.69 $7.41
Total cash flows from financing $281.34 $131.54 -$29.55 -$11.86
Effect of exchange rate -$0.08 -$0.66 -$0.05 $0.07
Change in cash and equivalents $8.3 -$139.78 -$6.64 $233.05
Fundamentals
Market cap $3.73B
Enterprise value $4.19B
Shares outstanding 113.89M
Revenue $1.96B
EBITDA -$11.42M
EBIT -$134.84M
Net Income -$99.68M
Revenue Q/Q 45.40%
Revenue Y/Y N/A
P/E ratio -37.47
EV/Sales 2.13
EV/EBITDA -366.55
EV/EBIT -31.05
P/S ratio 1.90
P/B ratio 3.49
Book/Share 9.39
Cash/Share 1.69
EPS -$0.88
ROA -3.77%
ROE -9.11%
Debt/Equity 1.34
Net debt/EBITDA -108.69
Current ratio 1.01
Quick ratio 1.01